Wilmington Savings Fund Society FSB Invests $150,000 in HealthEquity, Inc. (NASDAQ:HQY)

Wilmington Savings Fund Society FSB purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,832 shares of the company’s stock, valued at approximately $150,000.

Several other hedge funds have also recently added to or reduced their stakes in HQY. Holocene Advisors LP purchased a new position in HealthEquity in the 3rd quarter worth approximately $1,246,000. GSA Capital Partners LLP acquired a new stake in shares of HealthEquity in the third quarter valued at approximately $638,000. Natixis Advisors LLC lifted its position in HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after buying an additional 48,009 shares in the last quarter. Vaughan Nelson Investment Management L.P. grew its holdings in HealthEquity by 36.7% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock valued at $69,034,000 after buying an additional 226,563 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its stake in shares of HealthEquity by 29.4% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company’s stock worth $5,535,000 after acquiring an additional 14,573 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the sale, the director now owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,786 shares of company stock worth $4,140,387 in the last ninety days. 2.20% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Bank of America upped their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. The Goldman Sachs Group assumed coverage on HealthEquity in a research note on Friday, November 15th. They set a “neutral” rating and a $108.00 target price for the company. Barrington Research upped their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. Finally, Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Stock Up 3.5 %

Shares of HQY opened at $94.76 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. The stock has a market capitalization of $8.21 billion, a PE ratio of 86.94, a P/E/G ratio of 1.10 and a beta of 0.55. The company’s 50-day simple moving average is $94.60 and its 200-day simple moving average is $84.48. HealthEquity, Inc. has a 1 year low of $63.48 and a 1 year high of $105.82.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.